Esperion Therapeutics
ESPR
#6771
Rank
C$1.13 B
Marketcap
C$4.42
Share price
0.00%
Change (1 day)
38.59%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2026 (TTM): C$0.10 Billion

According to Esperion Therapeutics's latest financial reports the company's current earnings are C$0.41 Billion. In 2025 the company made an earning of C$88.57 Million, an increase over its 2024 earnings that were of C$10.42 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.10 B22.3%
2025 C$88.57 M749.49%
2024 C$10.42 M-104.99%
2023 -C$0.21 Billion-15.03%
2022 -C$0.25 Billion-20.61%
2021 -C$0.31 Billion84.28%
2020 -C$0.17 Billion35.75%
2019 -C$0.13 Billion-55.71%
2018 -C$0.28 Billion19.57%
2017 -C$0.24 Billion125.39%
2016 -C$0.11 Billion51.43%
2015 -C$68.44 Million36.45%
2014 -C$50.16 Million43.55%
2013 -C$34.94 Million145.26%
2012 -C$14.25 Million
2002 -C$40.62 Million-7.81%
2001 -C$44.06 Million15.03%
2000 -C$38.3 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$14.71 B 13,240.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$7.16 B 6,395.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-C$0.75 Billion-775.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-C$36.25 Million-132.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C$0.26 M-99.76%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.53 B 385.70%๐Ÿ‡บ๐Ÿ‡ธ USA